Fundz

Hikma Pharmaceuticals Appoints Rebecca Hall as Chief Financial Officer

PRIVATESep 24, 2026
New to company · from ViiV Healthcare“The incoming finance chief joins from ViiV Healthcare, the specialist HIV company majority-owned by British pharma major GSK (LSE: GSK), with Japan's Shionogi as a minority shareholder.”

Position

Chief Financial Officer

Company

Hikma Pharmaceuticals

Rebecca Hall
OhioManufacturingBiotechnologyHealth CarePharmaceutical

Description

Hikma Pharmaceuticals has announced the appointment of Rebecca Hall as its new chief financial officer and executive director. She is expected to officially join the leadership team in the first quarter of 2027.

Quick answer

Hikma Pharmaceuticals Appoints Rebecca Hall as Chief Financial Officer (September 24, 2026). Hikma Pharmaceuticals is based in Ohio, United States.

Who is the new Chief Financial Officer at Hikma Pharmaceuticals?
Hikma Pharmaceuticals named Rebecca Hall Chief Financial Officer, announced September 24, 2026.
What did Hikma Pharmaceuticals announce on September 24, 2026?
Hikma Pharmaceuticals has announced the appointment of Rebecca Hall as its new chief financial officer and executive director. She is expected to officially join the leadership team in the first quarter of 2027.
Where did Rebecca Hall work before joining Hikma Pharmaceuticals?
Rebecca Hall joins from ViiV Healthcare.
What does Hikma Pharmaceuticals do?
Hikma Pharmaceuticals is a leading player in the U.S. generic drug market.
Where is Hikma Pharmaceuticals based?
Hikma Pharmaceuticals is based in Ohio, United States.
Which similar companies made leadership changes around the same time?
Optimi Health (September 29, 2026), Tirupati Group (September 18, 2026), LSL Pharma Group (September 10, 2026) and Everest Medicines (October 9, 2026) also announced leadership changes within 45 days of Hikma Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Hikma Pharmaceuticals, and when

A new leader at Hikma Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Hikma Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hikma Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hikma Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hikma Pharmaceuticals

Location

Ohio, United States

About

Hikma Pharmaceuticals is a leading player in the U.S. generic drug market. The company specializes in the manufacturing of complex generics, particularly sterile injectables, aimed at addressing the growing demand for oncology and chronic-care drugs. With a significant expansion in Ohio, Hikma aims to solidify its position by leveraging AI-driven private markets for funding. The company is focused on producing over 12 billion doses annually by 2030.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hikma Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kristen
Likely contact at this company
••••••••@••••••••

See Kristen's verified email →

Hana
Senior decision-maker at this company
••••••••@••••••••

See Hana's verified email →

Rehab
Senior decision-maker at this company
••••••••@••••••••

See Rehab's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Hikma Pharmaceuticals's next move

Learn about Strategic plan

Hikma Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.